Article | November 11, 2020

Developing The Highest Purity PEGs And mPEGs For Pharmaceutical Applications

By Dr. Stefan Randl, Head of R&D, Evonik Health Care

Pharma Article LSC EX PEGs and mPEGs.jpg

PEGylation, or the covalent attachment of polyethylene glycol (PEG) to pharmaceutical molecules, has been utilized for more than 30 years to improve the bioavailability, stability, targeting and performance of drug products across a range of treatment areas including cancer, hepatitis, auto-immune disorders and diabetes. Some of the main advantages of PEGylated drugs include better water solubility due to the hydrophilicity of PEGs, and reduced levels of immunogenicity, enzymatic degradation and renal clearance.

Due to their strong clinical record for safety and functional versality, PEGs and PEG derivatives are now being applied not only across a wide variety of drug classes such as proteins, peptides, but also with advanced drug delivery systems such as micelles and nanoparticles as well as bioresorbable polymeric excipients such as PLG.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: